search
Back to results

Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness

Primary Purpose

Telangiectasis, Erythema

Status
Unknown status
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Pulsed dye laser
Intense pulsed light
Sponsored by
Bispebjerg Hospital
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Telangiectasis focused on measuring Telangiectasia, Skin redness

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All Sexes

Inclusion Criteria: 18 years or older Skin types I, II, III No previous laser or IPL treatment for the condition Exclusion Criteria: Younger than 18 years old Skin types IV, V, or VI Pregnant or lactating women Previous laser or IPL treatment for the condition Recent exposure to sun or sun-beds Treatment with oral retinoid within 6 months Tendency to produce hypertrophic scars or keloids

Sites / Locations

  • Bispebjerg HospitalRecruiting

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
September 13, 2005
Last Updated
July 23, 2007
Sponsor
Bispebjerg Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT00206921
Brief Title
Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness
Official Title
Pulsed Dye Laser and Intense Pulsed Light for the Treatment of Telangiectasia and Skin Redness
Study Type
Interventional

2. Study Status

Record Verification Date
December 2004
Overall Recruitment Status
Unknown status
Study Start Date
February 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
August 2005 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Bispebjerg Hospital

4. Oversight

5. Study Description

Brief Summary
The purpose of the study is to compare efficacy and adverse effects of pulsed dye laser and intense pulsed light in patients with skin telangiectasia and redness.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Telangiectasis, Erythema
Keywords
Telangiectasia, Skin redness

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Single
Allocation
Randomized

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
Pulsed dye laser
Intervention Type
Device
Intervention Name(s)
Intense pulsed light

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Eligibility Criteria
Inclusion Criteria: 18 years or older Skin types I, II, III No previous laser or IPL treatment for the condition Exclusion Criteria: Younger than 18 years old Skin types IV, V, or VI Pregnant or lactating women Previous laser or IPL treatment for the condition Recent exposure to sun or sun-beds Treatment with oral retinoid within 6 months Tendency to produce hypertrophic scars or keloids
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Merete Hædersdal, MD, PhD, DrMedSci
Phone
+45 35 31 60 02
Email
mhaedersdal@dadlnet.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Merete Hædersdal, MD, PhD, DrMedSci
Organizational Affiliation
Bispebjerg Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Bispebjerg Hospital
City
Copenhagen
State/Province
Copenhagen NV
ZIP/Postal Code
2400
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Merete Hædersdal, MD, PhD, DrMedSci
Phone
+4535316002
Email
mhaedersdal@dadlnet.dk

12. IPD Sharing Statement

Learn more about this trial

Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness

We'll reach out to this number within 24 hrs